Two complement fixation (CF) components were detected in all of the various preparations (mouse liver, brain, serum, and BHK-21 cell culture) of Oriboca examined by equilibrium density centrifugation. The CF components possessed a buoyant density of 1.21 and 1.18 g/ml, and they were precipitated by treatment with protamine. Analysis of Oriboca virus by rate zonal sedimentation separated three components. The most rapidly sedimenting component was the infectivity which cosedimented with a peak of hemagglutinating (HA) activity designated VHA. A second, more slowly sedimenting, noninfectious HA component (HA-2) was followed by a peak of CF activity which barely moved from the top of the gradient. The single rate zonal CF peak and the two density gradient CF components were broadly cross-reactive serologically with Murutucu antiserum. They could not be identified as Oriboca on the basis of their CF reactions with Murutucu and Oriboca antisera. Oriboca-infective virions possessed an equilibrium density of 1.20 g/ml if derived from BHK-21 cell culture fluid concentrates or mouse serum. Infective virions prepared from mouse brain or liver banded at a buoyant density of 1.17 to 1.18 g/ml. These density differences, along with observed differences in reactivity with protamine and in rate of neutralization, are consistent with the interpretation that these are related to the problem of whether the source preparations of Oriboca represented primarily intracellular or extracellular particles.
The serological relationships of group C arboviruses are characterized by an unusual pattern of antigenic sharing (2, 12) . For example, two member viruses are paired together by being indistinguishable by complement fixation (CF), yet each of the pair is more closely related to a different virus by hemagglutination-inhibition and neutralization tests. These patterns have been established not only by the use of laboratory prepared antisera, but also by results obtained with paired sera collected from infected human beings whose diagnosis was documented by virus isolation (12) . In addition, comprehensive cross-neutralization testing has been conducted under standardized conditions in tissue culture (9) . Relationships were in general accordance with those previously established by hemagglutination-inhibition testing.
It has been suggested that the CF antigen which is common to the group C viruses in the abovementioned pairs is a soluble antigen (12) . To understand and better explain the nature of the common antigen, studies were undertaken with Oriboca virus as a model group C arbovirus. The studies were concerned with the physical and antigenic characterization of the viral activities of Oriboca. Particular emphasis was given to the CF components of Oriboca virus preparations.
MATERIALS AND METHODS
Cell cultures and media. Stock cultures of Vero cells were grown in 32-ounce (about 0.946 liters) flint glass prescription bottles and transferred weekly by a 1:5 split. The cultures were grown in Eagle basal medium with Hanks balanced salt solution (HBSS) and 5% heat-inactivated adult calf serum. The maintenance medium for Vero cultures consisted of Eagle basal medium with Earle balanced salt solution and 2% heat-inactivated adult calf serum. The preparation of Vero cell cultures in 3-ounce (about 58.9 ml) flint glass prescription bottles and the preparation, growth, and handling of BHK-21 cell cultures has been reported previously (7, 8) .
Viruses. The BeAn 17 and BeAn 913 strains of Oriboca virus were used. Strain BeAn 913 (fourth mouse passage) was utilized for preparing suckling 53 INFECT. IMMUNITY mouse brain suspensions of Oriboca. This strain has a prolonged incubation in suckling mice and tends to multiply to a higher titer in the brain than in the liver. Strain BeAn 17 (10th mouse passage) was used to prepare suckling mouse liver suspensions, infective serum, and BHK-21 cell culture concentrates for analysis.
One-to three-day-old infant mice of the Charles River CD (R) 1 strain were infected by intracerebral inoculation for the preparation of Oriboca virus suspensions. Mouse brain and liver suspensions (10%) of Oriboca were prepared by homogenization in boratebuffered saline, pH 9.0. The suspensions were clarified by centrifugation at 10,000 rpm for 30 min and were stored at -70 C. A serum virus preparation was obtained by bleeding 2-day-old infected mice 30 to 36 h postinfection. The expressed serum was centrifuged at 2,000 rpm for 15 min, diluted 1: 2 to 1: 5 in borate saline buffer, and stored at -70 C.
Concentrates of BHK-21 cell culture-propagated Oriboca were prepared in the following manner. Mature monolayer cultures of BHK-21 grown in 32-ounce (about 0.946 liters) prescription bottles were inoculated with Oriboca virus at a multiplicity of approximately 0.1. After adsorption for 60 min at 37 C, the inoculum was removed and the cultures were washed two times with HBSS and maintained with Eagle basal medium with Earle balanced salt solution and 2% adult calf serum. After 18 to 24 h, the maintenance medium was removed and the cultures were washed twice with HBSS and refed with maintenance medium without calf serum. The maintenance medium was previously adjusted to pH 8.0 by the addition of 7.5% NaHCO3. After 12 to 18 h, when very early cytopathic effects (CPE) were just detectable, the infective fluids were harvested and centrifuged to remove gross cellular debris. The cell culture fluids were concentrated 30-to 60-fold by ultrafiltration in an Amicon Diaflo cell (Amicon Corp., Lexington, Mass.) fitted with an XM-50 membrane. The Oriboca cell culture fluid concentrates were stored at -70 C.
Infectivity assay. Serial 10-fold virus dilutions were plated onto monolayer cultures of Vero cells, adsorbed for 60 min at 37 C, and overlaid with 10 ml of a nutrient medium-agar mixture containing neutral red (7). Plaques were counted 5 to 7 days later.
Rabbit antiserum. Vero cell culture fluid concentrates of Oriboca virus were prepared in a manner identical to that described for Oriboca propagated in BHK-21 cell cultures. Separate lots of Vero-propagated Oriboca concentrates were treated with 0.2% sodium lauryl sulfate and 0.2% sodium deoxycholate. The sodium deoxycholate-treated viral concentrates were dialyzed against borate saline buffer to remove excess sodium deoxycholate. The removal of excess sodium lauryl sulfate was described elsewhere (4) .
Adult New Zealand white rabbits were immunized separately with one of the treated viral concentrates according to the following schedule: three weekly subcutaneous injections of treated viral antigen emulsified with an equal quantity (total of 5.0 ml) of Freund complete adjuvant; 4 weeks later, two weekly intravenous inoculations of treated virus (2.5 ml) alone; 3 weeks later, three weekly intravenous injections (2.5 to 3.5 ml); 2 weeks later, two additional weekly intravenous inoculations. The rabbits were bled 3 days after the last injection.
The Murutucu and Itaqui mouse antisera, immune ascitic fluids, and antigens used in this study were obtained from the WHO collection of the Yale Arbovirus Research Unit.
Kinetic neutralization assays. Preliminary experiments indicated that a 1:1,280 dilution of the rabbit antiserum (50% plaque reduction titer equaled 1:55,000) decreased the Oriboca input plaque count by more than 98% in a conventional 61-min plaquereduction neutralization test (11) . This dilution of antiserum was employed in all subsequent kinetic neutralization testing. Oriboca virus preparations under test were diluted to yield 50 to 100 plaques upon plating. Samples of the diluted virus preparations were held in an ice bath and mixed with heat-inactivated normal serum and antiserum diluted to 1:1,280. The serum-virus mixtures were incubated at 37 C, and both normal serum-virus and antiserum-virus samples were removed after 5, 20, and 40 min at 37 C. The samples were placed in an ice bath and plated in triplicate as soon as possible. A normal serumvirus sample plated after mixing was considered the zero-time sample.
HA, HI, and CF assays. Hemagglutination (HA) activity was assayed by a microtiter technique using the general principles outlined by Clarke 9 vol of virus suspension in an ice bath and allowed to stand with occasional shaking for 15 min. The protamine-treated virus preparation was centrifuged in the cold at 2,500 rpm for 10 min, the supernatant fluid was removed, and the precipitate was washed twice with cold distilled water. The precipitate was extracted with 9 vol of alkaline 1 M NaCl for at least 1 h at 4 C. The resulting extract was centrifuged lightly at 1,000 rpm for 5 min.
RESULTS
The viral activities of Oriboca prepared from different sources were initially characterized by buoyant density gradient centrifugation. Initially, CF antigen reactivity was monitored with both of the rabbit antisera described in Materials and Methods. The standard deviation inherent in the measurement of density for infective virions was calculated to be 0.004 for mouse liver preparations, 0.003 for mouse brain, 0.005 for mouse serum, and 0.002 for BHK-21 cell culture fluid concentrates. The results also illustrate that the infectivity of Oriboca prepared from brain and liver sources is reproducibly less dense than is the infectivity of Oriboca from the cell culture and mouse serum preparations. This aspect was further investigated later.
One must consider the possibility that the density differences of infective virions from different sources are a reflection of the absence of equilibrium after 17 h of centrifugation. Thus, the various preparations of Oriboca were centrifuged in sucrose-D2O density gradients under identical conditions as previously, with the exception that the centrifugation time was extended to 44 h. The results presented in Table 2 indicate that the viral activities apparently did not quite achieve equilibrium after 17 h of centrifugation. It is noted that the HA still cosediments with the infectivity at a buoyant density of 1.20 g/ml after 44 h of centrifugation. However, it must be emphasized that the differences which existed after 17 h still exist after 44 h of centrifugation although at slightly higher values. Thus, the infectivity of Oriboca virions prepared from different sources still differ in their density and there still are two CF components. In light of these observations, it was considered justifiable to use results obtained after 17 h of centrifugation as a characteristic in experiments shown in Fig. 3 and Tables 4 and 6. Analysis of Oriboca by rate zonal sedimentation. Oriboca virus preparations were further physically characterized by rate zonal sedimentation in 5 to 20% sucrose gradients. Three components are noted after rate zonal centrifugation of Oriboca propagated in BHK-21 cells (Fig. 2) . The majority of the recoverable infectivity has cosedimented to the bottom of the gradient with a rapidly sedimenting HA peak. This presumably represents intact infectious virions. A second, more slowly sedimenting HA peak is recovered in the upper one-third to one-fourth of the gradient and is considered to be relatively noninfectious. A slightly more slowly sedimenting peak of CF activity is noted at the top of the gradient. The CF peak is also considered as being noninfectious. In general, the infectivity titer in the peak fraction at the bottom of the gradient ranged from > 106 to > 107 plaque-forming units (PFU)/0. To study the density differences of infective Oriboca derived from various sources, we formulated a working hypothesis. First, we took note of the fact that the cell culture fluid and mouse serum preparations of Oriboca represented predominantly released or extracellular virus, and therefore we reasoned that the mouse liver and brain preparations may represent cell-associated or intracellular virus. Previously reported electron microscopy observations on the development of Bunyamwera supergroup viruses (6, 10) also weighed heavily in the formulation of this hypothesis. The substance of these observations indicated that there was a difference in the appearance of the surface and in the distribution of electron density between intracellular and extracellular particles. Thus, the physical state of the infectious virion (intracellular or extracellular) may account for differences in density as well as reflect differences in surface properties. Conceivably the two types of virions may therefore differ in their neutralizability and in their reactivity with protamine.
Kinetic neutralization experiments were set up by using virions derived from the four different sources of Oriboca: mouse liver, brain, Table 5 . Only the results obtained after protamine treatment of the liver and cell culture preparations are shown because they were identical to those obtained with the mouse brain and serum preparations, respectively. The Oriboca infectivity derived from liver or brain is markedly reduced with even the lowest concentration of protamine used. On the other hand, there is nonsignificant loss of infectivity from the cell culture of serum preparations after protamine treatment. It is further noted that significant quantities of CF activity were precipitated by protamine and that this CF activity was recoverable in the precipitate. Such was the case with all of the Oriboca virus preparations. In further experiments, concentrations of protamine up to 2.5 mg/ml were used and CF activity was still detectable in the treated supernatant fluid. Detectable quantities of HA did not appear to be precipitated by protamine. However, variable low levels of HA were recovered in the precipitate in other experiments when different lots of cell culture-propagated Oriboca were treated with protamine. In those instances it is not certain that the recovered HA activity represents true viral HA. It is also noteworthy that the infectivity lost as a result of protamine treatment of the liver and brain preparations was not recoverable from the precipitate. A variety of different methods was tried in an attempt to recover the infectivity, but all of them proved negative.
Thus, Oriboca virions prepared from different sources present clear differences in density, in neutralizability, and in reactivity with protamine. To examine at this point more directly, two types of Oriboca preparations were made from a single source of infected cells and were tested for differences in their properties. One type of preparation was considered as representing intracellular Oriboca virions, and the other would represent extracellular particles. Bottle cultures (32 ounce; about 0.946 liters) of Vero and BHK-21 cells were prepared and infected with Oriboca as described in Materials and Methods. At the first appearance of early CPE, the infective cell culture fluids were harvested and cleared to cellular debris by centrifugation. At this point cellular damage was minimal and these infected fluids were considered to represent released or extracellular particles. The infected cell sheets were then washed three times and subjected to alkaline extraction with borate-buffered saline for 60 min at room temperature. This peocedure is considered to extract intracellular particles from infected cell cultures (5) . Both types of preparations from each of the cell culture systems were then analyzed by density gradient centrifugation and for reactivity with protamine. The results of these experiments (Table 6) show that the virions in alkaline-extracted preparations possess a lower density which is very similar to that determined for the liver and brain sources of Oriboca. The densities of infective virions in the Vero and BHK-21 cell culture fluids were higher (1.18 g/ml) and entirely consistent with values determined previously for the BHK-21 cell culture fluid concentrates and mouse serum preparations of Oriboca virus. In a control experiment, infective virions in the cell culture fluids were mixed in equal quantity with doublestrength borate saline and allowed to stand at 4 C for 1 to 2 h before analysis by density gradient centrigugation. This treatment did not alter the density of the infective virions presumably representing extracellular particles.
None of the cell culture fluid preparations showed a significant loss in infectivity after treatment with protamine at concentrations ranging from 0.25 to 1.0 mg/ml. On the other hand, the alkaline extract preparations showed a consistent but small decrease in infectivity after protamine treatment. The small but significant decrease in infectivity and the variance in that decrease shown by the different alkaline extracts is probably attributable to the heterogenous composition of the alkaline extracts. DISCUSSION Analysis of Oriboca virus preparations by buoyant density centrifugation and rate zonal sedimentation have indicated that Oriboca consists of at least four physically distinct components. By rate zonal centrifugation, Oriboca preparations contain the infectious virion which cosediments with a small peak of HA activity (VHA), a slower-moving HA peak (HA-2), and a noninfectious peak of CF activity located at the top of the gradient. Two CF peaks with different densities (1.21 and 1.18 g/ml) are detected by buoyant density centrifugation.
The fact that these CF components were also detected in infective mouse serum indicates that they circulate in the host during infection. Similar observations have been reported for a nonstructural CF component of dengue 2 virus preparations (1). Although it is not certain that CF components circulate in the infected human, it is quite likely that they are elaborated during infection in humans. The same CF relationships observed with laboratory-produced antisera can be shown with convalescent sera taken from infected humans in which the infection was documented by virus isolation (12) .
It is curious that a single HA peak coincides with the peak of infectivity in buoyant density gradients, considering that there is appreciable noninfectious HA present as determined by rate zonal centrifugation. This observation was reproducible in three separate experiments and was probably not due to technical error. We have attempted to recycle both rate zonal HA peaks by buoyant density centrifugation. A buoyant density value has not been established for the rate zonal VHA because of extremely poor recovery of both infectivity and HA activity. The rate zonal HA-2 peak has been determined to possess an average buoyant density of 1.214 g/ml.
It is possible that the non-virion-associated (HA-2, LD CF, MD CF) components of Oriboca might have been derived as a result of fragmentation or disruption of Oriboca virions during centrifugation. The percentage of recovery of infectivity after all 17-h density gradient centrifugation experiments was 90 to more than 100% for mouse serum, more than 100% for cell culture fluid concentrates, 33 to 78% for brain preparations, and 26 to 87% for liver preparations of Oriboca. Similar orders of recoveries were noted after rate zonal sedimentation.
Since the non-virion-associated components were consistently detected regardless of the percentage of recovery of infectivity, the above possibility seems unlikely. Alternatively, these components may have resulted from degradation of the virion in vivo or they may represent components synthesized during infection which were not incorporated in the virion.
Both density gradient CF peaks and the single rate zonal CF peak were broadly crossreactive with Murutucu antiserum, such that they did not serve to differentiate between Murutucu and Oriboca. It appears that these CF components are the basis for the unusual antigenic sharing exhibited by group C arboviruses (12) . Both of the Oriboca HA types (VHA and HA-2) detected by rate zonal sedimentation were equally as reactive in homologous and heterologous HI reactions as was a standard Oriboca HA antigen preparation.
Carefully detailed electron microscopy examinations of Bunyamwera supergroup viruses have revealed a striking difference in the distribution of electron density between intracellular and extracellular particles (6) . Similar observations were previously reported by Murphy et al. (10) , though they were not emphasized by the latter investigators. Intracellular particles were observed to consist of an electron-dense membrane surrounding a relatively electronlucent core, whereas extracellular particles possessed an electron-dense core and an electronlucent envelope. Furthermore, intracellular particles were observed as having a rather smooth surface, whereas extracellular particles displayed a ragged surface. These observations suggest that there is an apparent change in the surface character of the virion. There is physical evidence on hand which supports this point. For example, we have noted a difference in the density of infective Oriboca virions depending on the source of the virus. Thus, infective Oriboca virions prepared from sources representing primarily extracellular particles possess a higher buoyant density and are neutralized at a faster rate, and their infectivity titer is not reduced upon treatment with protamine. In contrast, Oriboca virions prepared from sources believed to yield primarily intracellular particles possess a slightly lower buoyant density, are neutralized at a lesser rate, and are significantly reduced in infectivity titer by protamine treatment. It is reasonable to postulate that at least some of these differences reflect changes in surface properties of the virions and that these changes could be related to the intracellular or extracellular nature of the particles.
Our studies indicate that the infectivity lost as a result of protamine treatment was not subsequently recoverable from the precipitate in spite of the use of a variety of different techniques. However, the original investigations describing the use of protamine demonstrated that certain viruses other than arboviruses were precipitated by protamine and that the infectivity was easily recovered from the precipitate (14) . In our instance it is possible that the infective virions were not eluted, were eluted in an inactive form, or that they were not precipitated but were inactivated by some other mechanism. The variable appearance of low levels of HA activity in the precipitate when different Oriboca virus preparations were treated with protamine may reflect nonviral HA activity manifested by protamine (7) . However, it may also represent true viral HA which is entirely or partially masked by coprecipitated nonspecific HA inhibitors. Thus it has been noted that, under certain conditions, protamine treatment can result in the loss of infectivity and the precipitation of viral CF activity. Protamine has also precipitated a HA activity of Oropouche virus (13; D. H. Clarke, personal communication). Oropouche is a member of the Simbu group in the Bunyamwera supergroup and it is similar to Oriboca in morphology and mode of development (6) .
Available data indicate that the untreated Oriboca CF components not associated with the virion are probably responsible for the unusual antigenic relationship shown by group C arboviruses. Because they can be largely separated from Oriboca virus preparations, it should be possible to determine if they are related to any structural components of the virion or if they are nonstructural virus-directed antigens. Then one can more clearly define the antigenic makeup of the virus and rationally explain the antigenic sharing of group C arboviruses on the basis of structural or nonstructural, broadly cross-reactive antigenic components.
